img

Global Human Rabies Vaccines Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Human Rabies Vaccines Market Research Report 2024

Rabies Vaccine is an immunization drug used to prevent rabies in people who have been bitten by an animal or otherwise exposed to the rabies virus.
There are a number of rabies vaccines available that are both safe and effective. They can be used to prevent rabies, before or after exposure to the rabies virus, which is commonly caused by a dog bite or a bat bite.
According to Mr Accuracy reports’s new survey, global Human Rabies Vaccines market is projected to reach US$ 1352.3 million in 2034, increasing from US$ 1056 million in 2024, with the CAGR of 3.5% during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Human Rabies Vaccines market research.
Global Human Rabies Vaccine market leaders include Chengda Bio, Bharat Biotech, Bavarian Nordic, Sanofi-Pasteur, etc. All of the above hold over 65 percent market share.
Asia-Pacific is the largest consumption area, with a consumption market share close to 60%. Besides, North Americas is the second largest consumption area with a consumption market share of over 15%.
The classification of Human Rabies Vaccine includes Vero Cell, BHK, Chick Embryo Cell, Human Diploid Cells, and Others. In addition, the proportion of Vero Cell rabies vaccines is about 85%.
Human Rabies Vaccine is widely used for Pre-exposure and Post-exposure. The segment of Human Rabies Vaccine used for Post-exposure and the market share is over 70% of the share.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Human Rabies Vaccines market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Sanofi Pasteur，Inc.
Novartis Vaccines and Diagnostics Ltd.
Cadila Pharmaceuticals Ltd.
GlaxoSmithKline Biologicals
Merck＆Co Inc.
Wyeth pharmaceuticals
Berna Biotech Ltd.
Medimmune LLC
Segment by Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Others

Segment by Application


Pre-Exposure Prophylaxis
Post-Exposure Prophylaxis

Consumption by Region


North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Human Rabies Vaccines report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Human Rabies Vaccines Market Overview
1.1 Product Overview and Scope of Human Rabies Vaccines
1.2 Human Rabies Vaccines Segment by Type
1.2.1 Global Human Rabies Vaccines Market Value Comparison by Type (2024-2034)
1.2.2 Vero Cell Rabies Vaccine
1.2.3 BHK
1.2.4 Chick Embryo Cell Rabies Vaccine
1.2.5 Others
1.3 Human Rabies Vaccines Segment by Application
1.3.1 Global Human Rabies Vaccines Market Value by Application: (2024-2034)
1.3.2 Pre-Exposure Prophylaxis
1.3.3 Post-Exposure Prophylaxis
1.4 Global Human Rabies Vaccines Market Size Estimates and Forecasts
1.4.1 Global Human Rabies Vaccines Revenue 2018-2034
1.4.2 Global Human Rabies Vaccines Sales 2018-2034
1.4.3 Global Human Rabies Vaccines Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Human Rabies Vaccines Market Competition by Manufacturers
2.1 Global Human Rabies Vaccines Sales Market Share by Manufacturers (2018-2023)
2.2 Global Human Rabies Vaccines Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Human Rabies Vaccines Average Price by Manufacturers (2018-2023)
2.4 Global Human Rabies Vaccines Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Human Rabies Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Human Rabies Vaccines, Product Type & Application
2.7 Human Rabies Vaccines Market Competitive Situation and Trends
2.7.1 Human Rabies Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Human Rabies Vaccines Players Market Share by Revenue
2.7.3 Global Human Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Human Rabies Vaccines Retrospective Market Scenario by Region
3.1 Global Human Rabies Vaccines Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Human Rabies Vaccines Global Human Rabies Vaccines Sales by Region: 2018-2034
3.2.1 Global Human Rabies Vaccines Sales by Region: 2018-2023
3.2.2 Global Human Rabies Vaccines Sales by Region: 2024-2034
3.3 Global Human Rabies Vaccines Global Human Rabies Vaccines Revenue by Region: 2018-2034
3.3.1 Global Human Rabies Vaccines Revenue by Region: 2018-2023
3.3.2 Global Human Rabies Vaccines Revenue by Region: 2024-2034
3.4 North America Human Rabies Vaccines Market Facts & Figures by Country
3.4.1 North America Human Rabies Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Human Rabies Vaccines Sales by Country (2018-2034)
3.4.3 North America Human Rabies Vaccines Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Human Rabies Vaccines Market Facts & Figures by Country
3.5.1 Europe Human Rabies Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Human Rabies Vaccines Sales by Country (2018-2034)
3.5.3 Europe Human Rabies Vaccines Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Human Rabies Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Human Rabies Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Human Rabies Vaccines Sales by Country (2018-2034)
3.6.3 Asia Pacific Human Rabies Vaccines Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Human Rabies Vaccines Market Facts & Figures by Country
3.7.1 Latin America Human Rabies Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Human Rabies Vaccines Sales by Country (2018-2034)
3.7.3 Latin America Human Rabies Vaccines Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Human Rabies Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Human Rabies Vaccines Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Human Rabies Vaccines Sales by Country (2018-2034)
3.8.3 Middle East and Africa Human Rabies Vaccines Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Human Rabies Vaccines Sales by Type (2018-2034)
4.1.1 Global Human Rabies Vaccines Sales by Type (2018-2023)
4.1.2 Global Human Rabies Vaccines Sales by Type (2024-2034)
4.1.3 Global Human Rabies Vaccines Sales Market Share by Type (2018-2034)
4.2 Global Human Rabies Vaccines Revenue by Type (2018-2034)
4.2.1 Global Human Rabies Vaccines Revenue by Type (2018-2023)
4.2.2 Global Human Rabies Vaccines Revenue by Type (2024-2034)
4.2.3 Global Human Rabies Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global Human Rabies Vaccines Price by Type (2018-2034)
5 Segment by Application
5.1 Global Human Rabies Vaccines Sales by Application (2018-2034)
5.1.1 Global Human Rabies Vaccines Sales by Application (2018-2023)
5.1.2 Global Human Rabies Vaccines Sales by Application (2024-2034)
5.1.3 Global Human Rabies Vaccines Sales Market Share by Application (2018-2034)
5.2 Global Human Rabies Vaccines Revenue by Application (2018-2034)
5.2.1 Global Human Rabies Vaccines Revenue by Application (2018-2023)
5.2.2 Global Human Rabies Vaccines Revenue by Application (2024-2034)
5.2.3 Global Human Rabies Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global Human Rabies Vaccines Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Sanofi Pasteur，Inc.
6.1.1 Sanofi Pasteur，Inc. Corporation Information
6.1.2 Sanofi Pasteur，Inc. Description and Business Overview
6.1.3 Sanofi Pasteur，Inc. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Sanofi Pasteur，Inc. Human Rabies Vaccines Product Portfolio
6.1.5 Sanofi Pasteur，Inc. Recent Developments/Updates
6.2 Novartis Vaccines and Diagnostics Ltd.
6.2.1 Novartis Vaccines and Diagnostics Ltd. Corporation Information
6.2.2 Novartis Vaccines and Diagnostics Ltd. Description and Business Overview
6.2.3 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product Portfolio
6.2.5 Novartis Vaccines and Diagnostics Ltd. Recent Developments/Updates
6.3 Cadila Pharmaceuticals Ltd.
6.3.1 Cadila Pharmaceuticals Ltd. Corporation Information
6.3.2 Cadila Pharmaceuticals Ltd. Description and Business Overview
6.3.3 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product Portfolio
6.3.5 Cadila Pharmaceuticals Ltd. Recent Developments/Updates
6.4 GlaxoSmithKline Biologicals
6.4.1 GlaxoSmithKline Biologicals Corporation Information
6.4.2 GlaxoSmithKline Biologicals Description and Business Overview
6.4.3 GlaxoSmithKline Biologicals Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 GlaxoSmithKline Biologicals Human Rabies Vaccines Product Portfolio
6.4.5 GlaxoSmithKline Biologicals Recent Developments/Updates
6.5 Merck＆Co Inc.
6.5.1 Merck＆Co Inc. Corporation Information
6.5.2 Merck＆Co Inc. Description and Business Overview
6.5.3 Merck＆Co Inc. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Merck＆Co Inc. Human Rabies Vaccines Product Portfolio
6.5.5 Merck＆Co Inc. Recent Developments/Updates
6.6 Wyeth pharmaceuticals
6.6.1 Wyeth pharmaceuticals Corporation Information
6.6.2 Wyeth pharmaceuticals Description and Business Overview
6.6.3 Wyeth pharmaceuticals Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Wyeth pharmaceuticals Human Rabies Vaccines Product Portfolio
6.6.5 Wyeth pharmaceuticals Recent Developments/Updates
6.7 Berna Biotech Ltd.
6.6.1 Berna Biotech Ltd. Corporation Information
6.6.2 Berna Biotech Ltd. Description and Business Overview
6.6.3 Berna Biotech Ltd. Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Berna Biotech Ltd. Human Rabies Vaccines Product Portfolio
6.7.5 Berna Biotech Ltd. Recent Developments/Updates
6.8 Medimmune LLC
6.8.1 Medimmune LLC Corporation Information
6.8.2 Medimmune LLC Description and Business Overview
6.8.3 Medimmune LLC Human Rabies Vaccines Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Medimmune LLC Human Rabies Vaccines Product Portfolio
6.8.5 Medimmune LLC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Human Rabies Vaccines Industry Chain Analysis
7.2 Human Rabies Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Human Rabies Vaccines Production Mode & Process
7.4 Human Rabies Vaccines Sales and Marketing
7.4.1 Human Rabies Vaccines Sales Channels
7.4.2 Human Rabies Vaccines Distributors
7.5 Human Rabies Vaccines Customers
8 Human Rabies Vaccines Market Dynamics
8.1 Human Rabies Vaccines Industry Trends
8.2 Human Rabies Vaccines Market Drivers
8.3 Human Rabies Vaccines Market Challenges
8.4 Human Rabies Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Human Rabies Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Human Rabies Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Human Rabies Vaccines Market Competitive Situation by Manufacturers in 2024
Table 4. Global Human Rabies Vaccines Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Human Rabies Vaccines Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Human Rabies Vaccines Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Human Rabies Vaccines Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Human Rabies Vaccines Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Human Rabies Vaccines, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Human Rabies Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Human Rabies Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Human Rabies Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Human Rabies Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Rabies Vaccines as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Human Rabies Vaccines Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Human Rabies Vaccines Sales by Region (2018-2023) & (K Units)
Table 18. Global Human Rabies Vaccines Sales Market Share by Region (2018-2023)
Table 19. Global Human Rabies Vaccines Sales by Region (2024-2034) & (K Units)
Table 20. Global Human Rabies Vaccines Sales Market Share by Region (2024-2034)
Table 21. Global Human Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Human Rabies Vaccines Revenue Market Share by Region (2018-2023)
Table 23. Global Human Rabies Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Human Rabies Vaccines Revenue Market Share by Region (2024-2034)
Table 25. North America Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Human Rabies Vaccines Sales by Country (2018-2023) & (K Units)
Table 27. North America Human Rabies Vaccines Sales by Country (2024-2034) & (K Units)
Table 28. North America Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Human Rabies Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Human Rabies Vaccines Sales by Country (2018-2023) & (K Units)
Table 32. Europe Human Rabies Vaccines Sales by Country (2024-2034) & (K Units)
Table 33. Europe Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Human Rabies Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Human Rabies Vaccines Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Human Rabies Vaccines Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Human Rabies Vaccines Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Human Rabies Vaccines Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Human Rabies Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Human Rabies Vaccines Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Human Rabies Vaccines Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Human Rabies Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Human Rabies Vaccines Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Human Rabies Vaccines Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Human Rabies Vaccines Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Human Rabies Vaccines Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Human Rabies Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Human Rabies Vaccines Sales (K Units) by Type (2018-2023)
Table 51. Global Human Rabies Vaccines Sales (K Units) by Type (2024-2034)
Table 52. Global Human Rabies Vaccines Sales Market Share by Type (2018-2023)
Table 53. Global Human Rabies Vaccines Sales Market Share by Type (2024-2034)
Table 54. Global Human Rabies Vaccines Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Human Rabies Vaccines Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Human Rabies Vaccines Revenue Market Share by Type (2018-2023)
Table 57. Global Human Rabies Vaccines Revenue Market Share by Type (2024-2034)
Table 58. Global Human Rabies Vaccines Price (USD/Unit) by Type (2018-2023)
Table 59. Global Human Rabies Vaccines Price (USD/Unit) by Type (2024-2034)
Table 60. Global Human Rabies Vaccines Sales (K Units) by Application (2018-2023)
Table 61. Global Human Rabies Vaccines Sales (K Units) by Application (2024-2034)
Table 62. Global Human Rabies Vaccines Sales Market Share by Application (2018-2023)
Table 63. Global Human Rabies Vaccines Sales Market Share by Application (2024-2034)
Table 64. Global Human Rabies Vaccines Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Human Rabies Vaccines Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Human Rabies Vaccines Revenue Market Share by Application (2018-2023)
Table 67. Global Human Rabies Vaccines Revenue Market Share by Application (2024-2034)
Table 68. Global Human Rabies Vaccines Price (USD/Unit) by Application (2018-2023)
Table 69. Global Human Rabies Vaccines Price (USD/Unit) by Application (2024-2034)
Table 70. Sanofi Pasteur，Inc. Corporation Information
Table 71. Sanofi Pasteur，Inc. Description and Business Overview
Table 72. Sanofi Pasteur，Inc. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Sanofi Pasteur，Inc. Human Rabies Vaccines Product
Table 74. Sanofi Pasteur，Inc. Recent Developments/Updates
Table 75. Novartis Vaccines and Diagnostics Ltd. Corporation Information
Table 76. Novartis Vaccines and Diagnostics Ltd. Description and Business Overview
Table 77. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Novartis Vaccines and Diagnostics Ltd. Human Rabies Vaccines Product
Table 79. Novartis Vaccines and Diagnostics Ltd. Recent Developments/Updates
Table 80. Cadila Pharmaceuticals Ltd. Corporation Information
Table 81. Cadila Pharmaceuticals Ltd. Description and Business Overview
Table 82. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. Cadila Pharmaceuticals Ltd. Human Rabies Vaccines Product
Table 84. Cadila Pharmaceuticals Ltd. Recent Developments/Updates
Table 85. GlaxoSmithKline Biologicals Corporation Information
Table 86. GlaxoSmithKline Biologicals Description and Business Overview
Table 87. GlaxoSmithKline Biologicals Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. GlaxoSmithKline Biologicals Human Rabies Vaccines Product
Table 89. GlaxoSmithKline Biologicals Recent Developments/Updates
Table 90. Merck＆Co Inc. Corporation Information
Table 91. Merck＆Co Inc. Description and Business Overview
Table 92. Merck＆Co Inc. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Merck＆Co Inc. Human Rabies Vaccines Product
Table 94. Merck＆Co Inc. Recent Developments/Updates
Table 95. Wyeth pharmaceuticals Corporation Information
Table 96. Wyeth pharmaceuticals Description and Business Overview
Table 97. Wyeth pharmaceuticals Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Wyeth pharmaceuticals Human Rabies Vaccines Product
Table 99. Wyeth pharmaceuticals Recent Developments/Updates
Table 100. Berna Biotech Ltd. Corporation Information
Table 101. Berna Biotech Ltd. Description and Business Overview
Table 102. Berna Biotech Ltd. Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Berna Biotech Ltd. Human Rabies Vaccines Product
Table 104. Berna Biotech Ltd. Recent Developments/Updates
Table 105. Medimmune LLC Corporation Information
Table 106. Medimmune LLC Description and Business Overview
Table 107. Medimmune LLC Human Rabies Vaccines Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Medimmune LLC Human Rabies Vaccines Product
Table 109. Medimmune LLC Recent Developments/Updates
Table 110. Key Raw Materials Lists
Table 111. Raw Materials Key Suppliers Lists
Table 112. Human Rabies Vaccines Distributors List
Table 113. Human Rabies Vaccines Customers List
Table 114. Human Rabies Vaccines Market Trends
Table 115. Human Rabies Vaccines Market Drivers
Table 116. Human Rabies Vaccines Market Challenges
Table 117. Human Rabies Vaccines Market Restraints
Table 118. Research Programs/Design for This Report
Table 119. Key Data Information from Secondary Sources
Table 120. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Human Rabies Vaccines
Figure 2. Global Human Rabies Vaccines Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Human Rabies Vaccines Market Share by Type in 2024 & 2034
Figure 4. Vero Cell Rabies Vaccine Product Picture
Figure 5. BHK Product Picture
Figure 6. Chick Embryo Cell Rabies Vaccine Product Picture
Figure 7. Others Product Picture
Figure 8. Global Human Rabies Vaccines Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Human Rabies Vaccines Market Share by Application in 2024 & 2034
Figure 10. Pre-Exposure Prophylaxis
Figure 11. Post-Exposure Prophylaxis
Figure 12. Global Human Rabies Vaccines Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 13. Global Human Rabies Vaccines Market Size (2018-2034) & (US$ Million)
Figure 14. Global Human Rabies Vaccines Sales (2018-2034) & (K Units)
Figure 15. Global Human Rabies Vaccines Average Price (USD/Unit) & (2018-2034)
Figure 16. Human Rabies Vaccines Report Years Considered
Figure 17. Human Rabies Vaccines Sales Share by Manufacturers in 2024
Figure 18. Global Human Rabies Vaccines Revenue Share by Manufacturers in 2024
Figure 19. The Global 5 and 10 Largest Human Rabies Vaccines Players: Market Share by Revenue in 2024
Figure 20. Human Rabies Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 21. Global Human Rabies Vaccines Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 22. North America Human Rabies Vaccines Sales Market Share by Country (2018-2034)
Figure 23. North America Human Rabies Vaccines Revenue Market Share by Country (2018-2034)
Figure 24. U.S. Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Canada Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 26. Europe Human Rabies Vaccines Sales Market Share by Country (2018-2034)
Figure 27. Europe Human Rabies Vaccines Revenue Market Share by Country (2018-2034)
Figure 28. Germany Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. France Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. U.K. Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Italy Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Russia Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 33. Asia Pacific Human Rabies Vaccines Sales Market Share by Region (2018-2034)
Figure 34. Asia Pacific Human Rabies Vaccines Revenue Market Share by Region (2018-2034)
Figure 35. China Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. Japan Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. South Korea Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. India Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Australia Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Taiwan Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Indonesia Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Thailand Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Malaysia Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Philippines Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 45. Latin America Human Rabies Vaccines Sales Market Share by Country (2018-2034)
Figure 46. Latin America Human Rabies Vaccines Revenue Market Share by Country (2018-2034)
Figure 47. Mexico Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Brazil Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Argentina Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 50. Middle East & Africa Human Rabies Vaccines Sales Market Share by Country (2018-2034)
Figure 51. Middle East & Africa Human Rabies Vaccines Revenue Market Share by Country (2018-2034)
Figure 52. Turkey Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. Saudi Arabia Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. U.A.E Human Rabies Vaccines Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 55. Global Sales Market Share of Human Rabies Vaccines by Type (2018-2034)
Figure 56. Global Revenue Market Share of Human Rabies Vaccines by Type (2018-2034)
Figure 57. Global Human Rabies Vaccines Price (USD/Unit) by Type (2018-2034)
Figure 58. Global Sales Market Share of Human Rabies Vaccines by Application (2018-2034)
Figure 59. Global Revenue Market Share of Human Rabies Vaccines by Application (2018-2034)
Figure 60. Global Human Rabies Vaccines Price (USD/Unit) by Application (2018-2034)
Figure 61. Human Rabies Vaccines Value Chain
Figure 62. Human Rabies Vaccines Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries